A gene-based score for the risk stratification of stage IA lung adenocarcinoma

A gene-based score for the risk stratification of stage IA lung adenocarcinoma

Abstract Objective We aim to molecularly stratify stage IA lung adenocarcinoma (LUAD) for precision medicine. Methods Twelve multi-institution datasets (837 cases of IA) were used to classify the high- and low-risk types (based on survival status within 5 years), and the biological differences were...

Full description

Bibliographic Details
Main Authors: Yanlu Xiong, Yongfu Ma, Kun Liu, Jie Lei, Jinbo Zhao, Jianfei Zhu, Wenchen Wang, Miaomiao Wen, Xuejiao Wang, Ying Sun, Yabo Zhao, Yong Han, Tao Jiang, Yang Liu
Format: Article
Language:English
Published: BMC 2024-01-01
Series:Respiratory Research
Subjects:
LUAD
Stage IA
Risk stratification
Prognosis
IA score
IAExpSuv
Online Access:https://doi.org/10.1186/s12931-023-02647-4

Internet

https://doi.org/10.1186/s12931-023-02647-4

Similar Items